Quality of life and coronary insufficiency in men with myocardial infarction and coronary reperfusion
https://doi.org/10.15829/1728-8800-2011-4-45-51
Abstract
Aim. To analyze the association between quality of life (QoL) and recurrent coronary insufficiency (CI) within 12 months after primary, uncomplicated myocardial infarction (MI) in working-age men, who underwent various types of coronary reperfusion.
Material and methods. In total, 114 men aged <60 years — patients with primary, uncomplicated MI, were examined. CI recurrence was assessed clinically, based on typical angina (A) attacks. To diagnose silent CI, all patients underwent an exercise test (veloergometry) before the discharge, as well as 3, 6, and 12 months after MI. QoL was assessed with a Russian version of SF-36 questionnaire.
Results. In CI-free men from the percutaneous coronary intervention (PCI) group, some QoL scales demonstrated a significant improvement at 3, 6, and 12 months. In the thrombolytic therapy (TLT) group, all QoL scales were significantly improved. The maximal QoL score was observed at 12 months in both groups. Patients with angina had decreased QoL, with the minimal score observed for role functioning domains (median score 0 and 12,5 in PCI and TLT groups, respectively) and emotional status (33 and 16,7, respectively).
Conclusion. Regardless of the coronary reperfusion method in acute MI phase, CI-free patients demonstrated improved QoL, with the highest scores registered 12 months after MI. Angina recurrence affected physical and emotional role functioning in MI patients, restricting their daily life activities. However, recurrent CI did not affect social activity levels or the need for social interaction.
About the Authors
N. V. KuznetsovaRussian Federation
Yekaterinburg
Ya. L. Gabinskyi
Russian Federation
Yekaterinburg
References
1. Новик А.А., Ионова Т.И.Руководство по исследованию качества жизни в медицине. СПб.: Издательский дом “Нева”; М.: “ОЛМА-ПРЕСС Звездный мир” 2002; 320.
2. Аронов Д.М., Зайцев В.П. Методика оценки качества жизни больных с сердечно-сосудистыми заболеваниями. Кардиология 2002; 5: 92-5.
3. Петрова М.М, Айвазян Т.А., Фендюхин С.А. Качество жизни у мужчин, перенесших инфаркт миокарда. Кардиология 2000; 2: 65-6.
4. Симоненко В.Б., Сейидов В.Г., Захаров С.В. и др. Сравнение отдаленных результатов коронарной ангиопластики и стентирования в течение 1-го года после операции. Клин мед 2007; 2: 15-9.
5. Волков В.С., Виноградов В.Ф. Особенности социальнопсихологического статуса больных хронической ишемической болезнью сердца. Кардиология 1993; 3: 15-6.
6. Хадгезова А.Б., Айвазян Т.А., Померанцев В.П. и др. Динамика психологического статуса и качества жизни больных инфарктом миокарда в зависимости от тяжести течения постинфарктного периода. Кардиология 1997; 1: 37-40.
7. Ольбинская Л.И., Игнатенко С.Б. Оценка ближайших и отдаленных результатов качества жизни больных ишемической болезнью сердца при лечении нитровазодилататорами. РКЖ 1999; 4: 15-8.
8. Hanke H, Stroschneider Th, Oberhoff M, et al. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circulat Res 1990; 67(3): 651-9.
9. Schwartz R, Holmes D, Topol E. The Restenosis paradigm revisited: An alternative proposal for cellular mechanisms. JACC 1992; 20(5): 1284-93.
10. Klein LW, Avula SB, Uretz E, et al. Utility of various clinical, noninvasive, and invasive procedures for determining the causes of recurrence of myocardial ischemia or infarction >1 year after percutaneous transluminal coronary angioplasty. Am J Cardiol 1995; 75: 1003-6.
11. Suresh CG, Grant SC, Henderson RA, Bennett DH. Late symptom recurrence after successful coronary angioplasty: angiographic outcome. Int J Cardiol 1993; 42: 257-62.
12. Ware JE. SF-36 Health Survey. Manual and Interpretation Guide. Second Printing. Boston: The Health Institute; New England Medical Center, 1997.
Review
For citations:
Kuznetsova N.V., Gabinskyi Ya.L. Quality of life and coronary insufficiency in men with myocardial infarction and coronary reperfusion. Cardiovascular Therapy and Prevention. 2011;10(4):45-51. (In Russ.) https://doi.org/10.15829/1728-8800-2011-4-45-51